A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group (Q37310514)
Jump to navigation
Jump to search
scientific article published on February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group |
scientific article published on February 2009 |
Statements
1 reference
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group (English)
1 reference
Timothy C Griffin
1 reference
Sheila Weitzman
1 reference
Howard Weinstein
1 reference
Myron Chang
1 reference
Mitchell Cairo
1 reference
Robert Hutchison
1 reference
Bruce Shiramizu
1 reference
Joseph Wiley
1 reference
Deborah Woods
1 reference
Margaret Barnich
1 reference
Thomas G Gross
1 reference
Children's Oncology Group
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference